Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
Liminatus Pharma raised $1.9 million in gross proceeds by inducing existing warrant holders to exercise 10.34 million warrants at a reduced strike price of $0.18. In exchange, the company issued 20.688 million new unregistered warrants, also with a $0.18 strike price, effectively doubling the potential share count associated with this transaction.
Key figures
- Deal Value Usd
- 1900000
- Offering Price
- 0.18
- Shares Offered
- 10344000
- New warrant strike
- 0.18
- New warrants issued
- 20688000
- Warrant exercise price reduced to
- 0.18
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.